ANS Pharma   Report issue

For profit Phase 2
Founded: Brazil (2010)

Organization Overview

First Clinical Trial
2013
NCT02177643
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

ANS Pharma

Active Ingredients

Drugs in Phase 2 Trials (1)

diacerein (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Complications (Phase 2)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Insulin Resistance (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1